vinorelbine injection, usp solution
fresenius kabi canada ltd - vinorelbine (vinorelbine tartrate) - solution - 10mg - vinorelbine (vinorelbine tartrate) 10mg - antineoplastic agents
vinorelbine te arai
te arai biofarma limited - vinorelbine tartrate 27.7mg equivalent to vinorelbine 20mg; - capsule - 20 mg - active: vinorelbine tartrate 27.7mg equivalent to vinorelbine 20mg excipient: gelatin iron oxide yellow macrogol 400 polysorbate 80 purified water sorbitol titanium dioxide - vinorelbine is indicated in adults over 18. for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.
vinorelbine te arai
te arai biofarma limited - vinorelbine tartrate 41.55mg equivalent to vinorelbine 30mg; - capsule - 30 mg - active: vinorelbine tartrate 41.55mg equivalent to vinorelbine 30mg excipient: gelatin iron oxide red macrogol 400 polysorbate 80 purified water sorbitol titanium dioxide - vinorelbine is indicated in adults over 18. for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.
vinorelbine te arai
te arai biofarma limited - vinorelbine tartrate 110.8mg equivalent to vinorelbine 80mg; - capsule - 80 mg - active: vinorelbine tartrate 110.8mg equivalent to vinorelbine 80mg excipient: gelatin iron oxide yellow macrogol 400 polysorbate 80 purified water sorbitol titanium dioxide - vinorelbine is indicated in adults over 18. for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.
vinorelbine accord healthcare 10 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine
vinorelbine accord healthcare 10 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine
vinorelbine sandoz 10 mg/ml inf. sol. (conc.) i.v. vial
sandoz sa-nv - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine
vinorelbine sandoz 10 mg/ml inf. sol. (conc.) i.v. vial
sandoz sa-nv - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine
vinorelbine s.k. 20 mg
k.s.kim international (sk- pharma) ltd., israel - vinorelbine as tartrate - capsules soft - vinorelbine as tartrate 20 mg - vinorelbine - vinorelbine s.k. is indicated :- for the treatment of non small cell lung cancer. - for the treatment of advanced breast cancer
vinorelbine s.k. 30 mg
k.s.kim international (sk- pharma) ltd., israel - vinorelbine as tartrate - capsules soft - vinorelbine as tartrate 30 mg - vinorelbine - vinorelbine s.k. is indicated : - for the treatment of non small cell lung cancer - for the treatment of advanced breast cancer